Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Determination of the presence of epidermal growth factor receptor (EGFR) gene mutation is useful for predicting the efficacy of gefitinib. However, the survival rate following the initiation of treatment with gefitinib varies among individuals. A retrospective study was conducted to investigate the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Clin Oncol
Asıl Yazarlar: INOMATA, MINEHIKO, HAYASHI, RYUJI, YAMAMOTO, AZUSA, TOKUI, KOTARO, TAKA, CHIHIRO, OKAZAWA, SEISUKE, KAMBARA, KENTA, SUZUKI, KENSUKE, ICHIKAWA, TOMOMI, YAMADA, TORU, MIWA, TOSHIRO, KASHII, TATSUHIKO, MATSUI, SHOKO, TOBE, KAZUYUKI, IMURA, JOHJI
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2015
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486842/
https://ncbi.nlm.nih.gov/pubmed/26171184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.568
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller